HealthMode offers opportunities for clients looking to leverage digital biomarkers in their strategy

August 31, 2020 | Case Study

HealthMode is a company developing software to identify digital biomarkers that offer opportunities to nontraditional players like hardware, materials, and sensor companies to engage more intimately with the healthcare industry. While digital biomarkers are an increasingly hot topic in the healthcare world, it can be difficult to understand how they can be an opportunity. Biomarkers by themselves are not patentable, and although there is some room around patenting them as part of a novel process, they are not something that can be produced and sold. Instead of looking at them as a product, clients need to be looking at strategies surrounding digital biomarkers. While it is possible to develop software in-house to incorporate into hardware offerings, a strategy with fewer barriers to entry is to look at digital biomarkers as a signpost for new markets to enter and consider partnerships with companies like HealthMode as a way to enter those markets.

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978